Logo 20and 20tagline 20preview
Logo 20and 20tagline high 20resolution

SFA Therapeutics, Inc

A Major Advancement in Treating Chronic Inflammatory Diseases

  • Stage Product In Development
  • Industry Biotechnology
  • Location Jenkintown, PA, US
  • Currency USD
  • Founded December 2016
  • Employees 4
  • Incorporation Type C-corp
  • Website sfatherapeutics.com

Company Summary

SFA Therapeutics is a biotech with a novel immunomodulatory platform focused on chronic inflammatory diseases and cancer. Our vision is to change the practice of Medicine. Our drugs that modulate the immune system, downregulating NF-kB and RAS, controlling inflammation and cancer. Primary targets include psoriasis and liver diseases, e.g. Hepatitis B, NASH, liver cancer,. Other potential targets are uveitis, CLL/AML, and CAR-T side effects.

Team

  • Bc830ec9 65ce 4ad0 b47f c4a299ae6c18
    Founder and CEO

    Experienced drug developer, with over 25 years of R&D experience, involvement in 33 approved NDAs and 12 medical devices.

  • World-class hepatitis expert

  • GI microbiome expert

Advisors

Previous Investors

  • Default avatar
    Ben Franklin Technology Partners
    Unconfirmed
    Default avatar
    Axella Bioventures
    Unconfirmed